Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
0.75
0.07 (10.07%)
At close: Jun 16, 2025, 3:59 PM
0.75
1.06%
After-hours: Jun 16, 2025, 07:59 PM EDT
10.07% (1D)
| Bid | 0.72 |
| Market Cap | 90.11M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -15.2M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -1.33 |
| Forward PE | 0.37 |
| Analyst | Buy |
| Ask | 0.79 |
| Volume | 4,888,311 |
| Avg. Volume (20D) | 2,692,466 |
| Open | 0.72 |
| Previous Close | 0.68 |
| Day's Range | 0.71 - 0.75 |
| 52-Week Range | 0.20 - 1.10 |
| Beta | 2.00 |
About UNCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UNCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for UNCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
-40.88%
Unicycive Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
7 months ago
+20.24%
Unicycive Therapeutics shares are trading higher after the company announced poster presentations for Oxylanthanum Carbonate and UNI-494 at the American Society of Nephrology Kidney Week 2024
